Análisis descriptivo de la prescripción de antipsicóticos atípicos de uso compasivo en el área sanitaria de Ferrol

Neurología - Tập 25 - Trang 300-308 - 2010
D. Santos-García1, M. Macías1, A. Casás-Martínez2, M. Llaneza1, J. Abella1, A. Aneiros1, H. Santos1, G. Domínguez-Urbistondo2, B. Salazar-Laya2
1Sección de Neurología, Hospital A. Marcide, Ferrol, La Coruña, España
2Servicio de Farmacia, Hospital A. Marcide, Ferrol, La Coruña, España

Tài liệu tham khảo

Factor, 2001, Risperidone in Parkinson's disease, Mov Disord., 17, 221, 10.1002/mds.1258

Kulisevsky, 2003, Antipsicóticos y efectos extrapiramidales, Neurología., 18, 262

Grupo de Estudio de Neurología de la Conducta y Demencias. Sociedad Española de Neurología. Guía oficial para la práctica clínica en demencias: conceptos, criterios y recomendaciones 2009. Barcelona: Prous Science; 2009.

Byerly, 2001, Antipsychotic medications and the elderly: effects on cognition and implications for use, Drugs Aging., 18, 45, 10.2165/00002512-200118010-00004

Clozapine. Lancet. 1989; 1:1430–2.

Ros-Montalbán, 2002, Ziprasidona: eficacia clínica, Actas Esp Psiquiatr., 30, 10

Tarsy, 2002, Effects of newer antipsychotics on extrapyramidal function, CNS Drugs., 12, 23, 10.2165/00023210-200216010-00003

Turkoz, 2008, Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia, Neuropsychiatr Dis Treat., 4, 949

Qiu, 2007, The epidemiology of the dementias: An update, Curr Opin Psychiatry., 20, 380, 10.1097/YCO.0b013e32816ebc7b

Fratiglioni, 2000, Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Resarch Group, Neurology., 54, S10

Bermejo-Pareja, 2008, Incidence and subtypes of dementia in tree elderly populations of central Spain, J Neurol Sci., 264, 63, 10.1016/j.jns.2007.07.021

Neary, 2005, Frontotemporal dementia, Lancet Neurol., 4, 771, 10.1016/S1474-4422(05)70223-4

López-Pousa, 2005, Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild to moderate Alzheimer's disease over a 6-month period, Dement Geriatr Cogn Disord., 19, 189, 10.1159/000083498

Gauthier, 2002, Efficacy of donepezil on behavioural symptoms in patients with moderate to severe Alzheimer's disease, Int Psychogegeriatr., 14, 389, 10.1017/S104161020200858X

Holmes, 2004, The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer's disease, Neurology., 63, 214, 10.1212/01.WNL.0000129990.32253.7B

Cummings, 2005, Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study, Am J Geriatr Pharmacother., 3, 137, 10.1016/S1543-5946(05)80020-0

Patterson, 2004, A 6 month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimeŕs disease, Int J Clin Pract., 58, 144, 10.1111/j.1368-5031.2004.0107.x

Gauthier, 2008, Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis, Int J Geriatr Psychiatry., 23, 537, 10.1002/gps.1949

Wilcock, 2008, Memantine for agitation/aggresion and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies, J Clin Psychiatry., 69, 341, 10.4088/JCP.v69n0302

Kozman, 2006, Pharmacological management of behavioural and psychological disturbance in dementia, Hum Psychopharmacol., 21, 1, 10.1002/hup.745

López-Pousa, 2009, Tratamiento farmacológico de los síntomas cognitivos y los síntomas conductuales y psicológicos, 417

Rocca, 2007, Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study, Psychiatry Clin Neurosci., 61, 622, 10.1111/j.1440-1819.2007.01729.x

Sultzer, 2008, Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial, Am J Psychiatry., 165, 844, 10.1176/appi.ajp.2008.07111779

Gareri, 2004, Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD), Arch Gerontol Geriatr Suppl., 9, 207, 10.1016/j.archger.2004.04.029

Street, 2000, Olanzapine treatment of psychotic and behavioural sumptoms in patients with Alzheimer disease in nursing care facilities, Arch Gen Psychiatry., 57, 968, 10.1001/archpsyc.57.10.968

Mintzer, 2001, Olanzapine in the treatment of anxiety symptoms due to Alzheimeŕs disease: a post hoc analysis, Int J Geriatri Psychiatry., 16, S71, 10.1002/1099-1166(200112)16:1+<::AID-GPS568>3.0.CO;2-M

Tariot, 2000, Long term use of quetiapine in elderly patients with psychotic disorders, Clin Ther., 22, 1068, 10.1016/S0149-2918(00)80085-5

Fernandez, 1999, Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease, Mov Disord., 14, 484, 10.1002/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO;2-B

Fernandez, 2000, Quetiapine for L-dopa-induced psychosis in Parkinson's disease, Neurology., 55, 899, 10.1212/WNL.55.6.899

Wainer, 2000, Quetiapine for L-dopa-induced psychosis in Parkinson's disease, Neurology., 54, 1538, 10.1212/WNL.54.7.1538

Poewe, 2005, Treatment of dementia with Lewy bodies and Parkinson's disease dementia, Mov Disord., 20, S77, 10.1002/mds.20544

Cole, 2005, Ziprasidone for agitation or psychosis in dementia: four cases, Int J Psychiatry Med., 35, 91, 10.2190/NAMG-XXGG-WDVY-GX04

Gómez-Esteban, 2005, Use of ziprasidone in parkinsonian patients with psychosis, Clin Neuropharmacol., 28, 111, 10.1097/01.wnf.0000164297.91643.ff

Schneider, 2005, Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials, JAMA., 294, 1934, 10.1001/jama.294.15.1934

Thông tin
Thông tin xuất bản

Neurología

Tập 25

300-308

Thông tin tác giả